Edition:
United States

Unilife Corp (UNIS.OQ)

UNIS.OQ on NASDAQ Stock Exchange Global Market

1.74USD
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
$1.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
16,605
52-wk High
$7.30
52-wk Low
$1.58

UNIS.OQ

Chart for UNIS.OQ

About

Unilife Corp is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted... (more)

Overall

Beta: -1.02
Market Cap(Mil.): $31.39
Shares Outstanding(Mil.): 18.15
Dividend: --
Yield (%): --

Financials

  UNIS.OQ Industry Sector
P/E (TTM): -- 34.27 30.15
EPS (TTM): -5.15 -- --
ROI: -120.34 12.76 13.05
ROE: -- 14.81 14.20

BRIEF-Unilife says investigation identifies no material financial loss

* Unilife - on May 8, co announced investigation into violations of policies, procedures, possible violations of laws, regulations by former CEO Alan Shortall

Nov 14 2016

BRIEF-Unilife delays result, investigating possible violations by former CEO

* Unilife - co's 2016 form 10-Q , 2016 form 10-k had been delayed as a result of co's investigation into possible violations of law and regulation by co's former CEO, Alan Shortall Source text for Eikon: Further company coverage:

Nov 10 2016

BRIEF-Unilife Corporation provides business update

* Unilife Corp - Revenue for Q4 of fiscal 2016 was $6.3 million compared to $3.5 million

Nov 02 2016

BRIEF-Unilife Corp implemented cost reduction measures

* Unilife Corp - reduced workforce to approximately 140 employees

Oct 24 2016

More From Around the Web

Earnings vs. Estimates